Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7401820 | 0.87 | ALDH1A1 (0.49) | PTGS2ALDH1A1CYP2C9CYP2C19MAPT | |
| SCHEMBL16332495 | 0.84 | GAA (0.59) | ALDH1A1MAPTPOLBGAASMN1; SMN2 | |
| SCHEMBL2116437 | 0.84 | PTGS2 (0.66) | PTGS2ALDH1A1CYP2C9CYP2C19MAPT | |
| SCHEMBL14198621 | 0.83 | ALDH1A1 (0.58) | ALDH1A1MAPTKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL14198501 | 0.83 | L3MBTL1 (0.48) | CYP2C19MAPTKMT2APOLBL3MBTL1 | |
| SCHEMBL13168175 | 0.83 | L3MBTL1 (0.44) | CYP2C19MAPTKMT2APOLBL3MBTL1 | |
| SCHEMBL10299626 | 0.82 | PTGS2 (0.57) | PTGS2ALDH1A1CYP2C9CYP2C19MAPT | |
| SCHEMBL13168071 | 0.82 | SMN1; SMN2 (0.49) | ALDH1A1MAPTKMT2AMEN1GAA | |
| SCHEMBL11660766 | 0.81 | ALDH1A1 (0.50) | PTGS2ALDH1A1CYP2C9CYP2C19MAPT | |
| SCHEMBL13168187 | 0.81 | SMN1; SMN2 (0.43) | CYP2C19MAPTKMT2APOLBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7795347-B2 | Multi-branched polymer, process for producing the same, and applications thereof | MITSUI CHEMICALS, INC. (JP) | 2010-09-14 | — | — | US | disclosed |
| US-7795347-B2 | Multi-branched polymer, process for producing the same, and applications thereof | MITSUI CHEMICALS, INC. (JP) | 2010-09-14 | — | — | US | disclosed |
| US-7705065-B2 | Photoinitiator functionalized with alkoxy groups | XEROX CORPORATION (US) | 2010-04-27 | — | — | US | disclosed |
| US-7705065-B2 | Photoinitiator functionalized with alkoxy groups | XEROX CORPORATION (US) | 2010-04-27 | — | — | US | disclosed |
| US-7705065-B2 | Photoinitiator functionalized with alkoxy groups | XEROX CORPORATION (US) | 2010-04-27 | — | — | US | disclosed |
| US-20090062418-A1 | NOVEL PHOTOINITIATORS | XEROX CORPORATION (US) | 2009-03-05 | — | — | US | disclosed |
| US-20090062418-A1 | NOVEL PHOTOINITIATORS | XEROX CORPORATION (US) | 2009-03-05 | — | — | US | disclosed |
| US-20090062418-A1 | NOVEL PHOTOINITIATORS | XEROX CORPORATION (US) | 2009-03-05 | — | — | US | disclosed |
| EP-1457512-B1 | Multi-branched polymer, process for producing the same, and applications thereof | MITSUI CHEMICALS INC (JP) | 2008-05-07 | — | — | EP | disclosed |
| EP-0691959-B1 | HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS | ZENECA LTD (GB) | 1998-07-22 | — | — | EP | disclosed |
| US-5728701-A | INHIBIT PLATELET AGGREGATION | ZENECA LIMITED (GB) | 1998-03-17 | — | — | US | disclosed |
| EP-0825184-A1 | Heterocyclic derivatives as platelet aggregation inhibitors | ZENECA LIMITED (GB) | 1998-02-25 | — | — | EP | disclosed |
| US-5652242-A | 3-METHYL-4-(4-(4-(4-PYRIDYL)PIPERAZIN-1-YL)PHENOXY)BURYIC ACID, AMIDE OR ESTER; INHIBITORS OF BINDING OF FIBRINOGEN TO GLYCOPROTEIN | ZENECA LIMITED (GB) | 1997-07-29 | — | — | US | disclosed |
| US-5563141-A | INHIBIT CELL ADHESION FOR EXAMPLE, PLATELET AGGRE GATION | ZENECA LIMITED (GB) | 1996-10-08 | — | — | US | disclosed |
| US-5556977-A | ANTIAGGLOMERANTS FOR CELLS, ANTICOAGULANTS, ANTIISCHEMIC AGENTS USING PYRIDINYLPIPERAZINE DERIVATIVES | ZENECA LIMITED (GB) | 1996-09-17 | — | — | US | disclosed |
| CN-1120334-A | Heterocyclic derivatives as platelet aggregation inhibitors | ZENECA LTD (GB) | 1996-04-10 | — | — | CN | disclosed |
| EP-0691959-A1 | HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1996-01-17 | — | — | EP | disclosed |
| EP-0690847-A1 | HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1996-01-10 | — | — | EP | disclosed |
| WO-1994022835-A2 | HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1994-10-13 | — | — | WO | disclosed |
| WO-1994022834-A1 | HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1994-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062418-A1 | NOVEL PHOTOINITIATORS | PPOX, FTO, CBR3 | PTGS2 437/4885ALDH1A1 281/4885CYP2C9 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.